Differentiated Thyroid Carcinoma Long‐Term Prognostic Factors
International Journal of Surgical Oncology · 2024
DOI: 10.1155/2024/1067447 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Surgical Oncology, 2024. Verfasst von Pacheco-Ojeda Luis und 4 weiteren Autor:innen. Beteiligte Einrichtung: Surgery Service Metropolitano Hospital, Quito, Ecuador. Hauptthemen laut MEDLINE: Thyroid Neoplasms, Adenocarcinoma, Follicular, Thyroidectomy, Iodine Radioisotopes. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Thyroid cancer is the most common cancer in women in Ecuador.
Objective
The aim of this study was to determine the demographics and clinical and treatment variables of patients with papillary or follicular thyroid cancer, referred to as differentiated thyroid cancer (DTC), treated at a third‐level hospital in Quito, Ecuador.
Methods
We reviewed retrospectively the medical records of patients with DTC, who underwent surgical treatment, from 1990 to 2019. Data included demographics, pathological information, clinical stage, type of surgery, and radioactive iodine (RAI) adjuvant therapy. Patients were monitored for up to 29 years (median follow‐up time 6.9 years).
Results
The corrected overall 5‐, 10‐, 20‐, and 30‐year survival rates (Kaplan–Meier) were 93%, 85%, 70%, and 63%, respectively. On univariate analysis, age, histological type, tumor grade, histological variants, capsular invasion, vascular invasion, tumor size, clinical stage, distant metastases at diagnosis, surgical margins, extrathyroidal invasion, radioactive iodine adjuvant treatment, and locoregional recurrence were found to be significant prognostic factors. In a multivariate analysis, the following independent variables: age over 55 years, extrathyroidal spread, metastasis at diagnosis, and stage II to IV raised the risk of death (hazard risk) (HR).
Conclusions
Age over 55 years, extrathyroidal spread, metastasis at diagnosis, and advanced clinical stage were found to have a harmful prognosis and an increased risk of death in a series of Ecuadorian patients surgically treated for a DTC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Surgery Service Metropolitano Hospital, Quito, Ecuador.
- Endocrinology Service Specialities Hospital Carlos Andrade Marín, Quito, Ecuador.
- Faculty of Medical Sciences Central University, Quito, Ecuador.
- San Francisco de Quito University, Quito, Ecuador.
ORCID-Profile: Pacheco-Ojeda Luis, Martínez-Jaramillo Ana Lucía, Romo-Castillo Hugo, Recalde-Maldonado Ramiro, Cañizares-Quisiguiña Stalin
Zitieren
APA
Luis, P. O., Lucía, M. A., Hugo, R. C., Ramiro, R. M., & Stalin, C. Q. (2024). Differentiated Thyroid Carcinoma Long‐Term Prognostic Factors. International Journal of Surgical Oncology. https://doi.org/10.1155/2024/1067447
Vancouver
Luis PO, Lucía MA, Hugo RC, Ramiro RM, Stalin CQ. Differentiated Thyroid Carcinoma Long‐Term Prognostic Factors. International Journal of Surgical Oncology. 2024. doi:10.1155/2024/1067447
BibTeX
@article{Luis2024,
author = {Luis, Pacheco-Ojeda and Lucía, Martínez-Jaramillo Ana and Hugo, Romo-Castillo and Ramiro, Recalde-Maldonado and Stalin, Cañizares-Quisiguiña},
title = {Differentiated Thyroid Carcinoma Long‐Term Prognostic Factors},
journal = {International Journal of Surgical Oncology},
year = {2024},
doi = {10.1155/2024/1067447}
}
EUVIMED